Market Research Logo

Nicaragua Pharmaceuticals & Healthcare Q2 2018

Nicaragua Pharmaceuticals & Healthcare Q2 2018

BMI View:

Nicaragua’s pharmaceutical market growth will be supported by government efforts to expand universal healthcare in anattempt to make it a higher priority market within Latin and Central America. However, the country will remain a relativelyunattractive market for pharmaceutical companies, deterred by downside risks such as the small absolute market size, low percapita pharmaceutical expenditure and the persistently challenging business environment. We maintain our view that whenmultinational drugmakers consider investment or expansion into Central America, Costa Rica remains the more attractive choice.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Industry Risk/Reward Index
Americas Pharmaceuticals & Healthcare Risk/Reward Index
Regulatory Development
Market Overview
Competitive Landscape
Demographic Forecast
Nicaragua - Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report